K
Kaixian Chen
Researcher at Chinese Academy of Sciences
Publications - 403
Citations - 11476
Kaixian Chen is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Virtual screening & Chemistry. The author has an hindex of 47, co-authored 380 publications receiving 9209 citations. Previous affiliations of Kaixian Chen include Shanghai University & East China University of Science and Technology.
Papers
More filters
Journal ArticleDOI
Conformational transition of amyloid β-peptide
TL;DR: The dynamic feature revealed by the long-time molecular dynamics simulations rationalized several experimental observations for Aβ40 aggregation and amyloid fibril formation and is beneficial to understanding the mechanism of amyloids formation and designing the compounds for inhibiting the aggregation of Aβ and amymbrane fibrils.
Journal ArticleDOI
In silico ADME/T modelling for rational drug design
Yulan Wang,Jing Xing,Yuan Xu,Nannan Zhou,Jianlong Peng,Zhaoping Xiong,Xian Liu,Xiaomin Luo,Cheng Luo,Kaixian Chen,Mingyue Zheng,Hualiang Jiang +11 more
TL;DR: The development of in silico models for some physicochemical parameters, ADME properties and toxicity evaluation, with an emphasis on the modelling approaches thereof, their application in drug discovery, and the potential merits or deficiencies of these models are introduced.
Journal ArticleDOI
Cinanserin Is an Inhibitor of the 3C-Like Proteinase of Severe Acute Respiratory Syndrome Coronavirus and Strongly Reduces Virus Replication In Vitro
Lili Chen,Chunshan Gui,Xiaomin Luo,Qingang Yang,Stephan Günther,Elke Scandella,Christian Drosten,Donglu Bai,Xichang He,Burkhard Ludewig,Jing Chen,Haibin Luo,Yiming Yang,Yifu Yang,Jian-Ping Zou,Volker Thiel,Kaixian Chen,Jianhua Shen,Xu Shen,Hualiang Jiang,Hualiang Jiang +20 more
TL;DR: It is demonstrated that the old drug cinanserin is an inhibitor of SARS-CoV replication, acting most likely via inhibition of the 3CL proteinase.
Journal ArticleDOI
A Series of α-Heterocyclic Carboxaldehyde Thiosemicarbazones Inhibit Topoisomerase IIα Catalytic Activity
He Huang,Qin Chen,Xin Ku,Linghua Meng,Liping Lin,Xiang Wang,Caihua Zhu,Yi Wang,Zhi Chen,Ming Li,Hualiang Jiang,Kaixian Chen,Jian Ding,Hong Liu +13 more
TL;DR: Results about the mechanisms involved in the anticancer activities of thiosemicarbazones will aid in the rational design of novel topoisomerase II-targeted drugs and will provide insights into the discovery and development of novel cancer therapeutics based on the dual activity to chelate iron and to inhibit the catalytic activity of topoisomersase IIalpha.
Journal ArticleDOI
pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analyses.
Jinzhi Tan,Koen H.G. Verschueren,Kanchan Anand,Jianhua Shen,Maojun Yang,Yechun Xu,Zihe Rao,Janna Bigalke,Burkhard Heisen,Jeroen R. Mesters,Kaixian Chen,Xu Shen,Hualiang Jiang,Rolf Hilgenfeld +13 more
TL;DR: The conformational flexibility of the Mpro is assessed by analysis of multiple crystal structures (including two new crystal forms) and by molecular dynamics calculations and explains the pH-activity profile of the enzyme.